OSE Immunotherapeutics, Inserm and Nantes University Partner on Immunotherapy Read More » September 26, 2025
CSL Vifor and Travere Therapeutics Support Updated KDIGO IgA Nephropathy Guidelines Read More » September 26, 2025
Oculis to Present Positive Phase 2 ACUITY Trial Results at ECTRIMS 2025 Read More » September 22, 2025
JCR Pharmaceuticals and Alexion Reach Milestone in Neurodegenerative Program Read More » September 19, 2025
